Jinzi Jason Wu's most recent trade in Sagimet Biosciences Inc - Ordinary Shares - Class A was a trade of 108,471,634 Series E Preferred Stock done . Disclosure was reported to the exchange on July 18, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sagimet Biosciences Inc - ... | Jinzi Jason Wu | Director | 18 Jul 2023 | 108,471,634 | 0 | - | - | Series E Preferred Stock | ||
Sagimet Biosciences Inc - ... | Jinzi Jason Wu | Director | 18 Jul 2023 | 23,041,474 | 0 | - | - | Series F Preferred Stock | ||
Sagimet Biosciences Inc - ... | Jinzi Jason Wu | Director | 18 Jul 2023 | 1,654,701 | 1,654,701 | - | - | Series A Common Stock | ||
Sagimet Biosciences Inc - ... | Jinzi Jason Wu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 23,216 | 23,216 | - | - | Stock Option (Right to Buy) | |
Sagimet Biosciences Inc - ... | Jinzi Jason Wu | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 23,216 | 0 | - | - | Stock Option (Right to Buy) |